Expression of hormone receptors, Bcl‑2, Cox‑2 and Ki67 in benign endometrial polyps and their association with obesity

Pinheiro,Anderson; Antunes,Armando; Andrade,Liliana; De Brot,Louise; Pinto‑Neto,Aarão Mendes; Costa‑Paiva,Lúcia

doi:10.3892/mmr.2014.2125

Expression of hormone receptors, Bcl‑2, Cox‑2 and Ki67 in benign endometrial polyps and their association with obesity

Authors:
- Anderson Pinheiro
- Armando Antunes
- Liliana Andrade
- Louise De Brot
- Aarão Mendes Pinto‑Neto
- Lúcia Costa‑Paiva
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, State University of Campinas‑UNICAMP School of Medicine, Campinas, São Paulo 13083‑881, Brazil, Department of Anatomical Pathology, A.C. Camargo Hospital, São Paulo 01509-010, Brazil
Published online on: April 9, 2014 https://doi.org/10.3892/mmr.2014.2125
Pages: 2335-2341

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study examined the immunoexpression of the estrogen receptor (ER), the progesterone receptor (PR), B‑cell lymphoma 2 (Bcl‑2), cyclooxygenase‑2 (Cox‑2) and Ki67 in endometrial polyps and their association with obesity. In total, 515 premenopausal and postmenopausal females undergoing hysteroscopy with histological diagnosis of benign polyps were included. The immunohistochemical expression of the ER, PR, Bcl‑2, Cox‑2 and Ki67 was compared between obese and non‑obese females. The median final score demonstrated a higher PR expression in the stromal and glandular compartments of postmenopausal obese females as compared with no‑obese females. However, in this group, there was no difference in regard to the ER. No difference in hormone receptor expression was identified among premenopausal females. In postmenopausal females, the immunoexpression of Cox‑2 and Bcl‑2 in the glandular epithelium was higher in obese than in non‑obese females. Among premenopausal females, obese females demonstrated a higher Bcl‑2 expression in the glandular epithelium than non‑obese females. There were no differences in Ki67 expression between obese and non‑obese females. Polyps from obese females had a higher PR expression in the glandular and stromal compartments. The expression of Cox‑2 and Bcl‑2 was higher in the glandular compartment. These data suggested that the etiology and pathogenesis of polyps in obese females appear to be associated with the PR, the inhibition of apoptosis and cellular mechanisms linked with inflammation.

View Figures

View References

1	World Health Organization (WHO). Obesity and overweight. http://www.who.int/mediacentre/factsheets. Accessed 22 May, 2012
2	Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, et al: Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause. 15:584–602. 2008. View Article : Google Scholar : PubMed/NCBI
3	Gouveia DA, Bahamondes L, Aldrighi JM, Tamanaha S, Ribeiro AL and Aoki T: Prevalence of endometrial injury in asymptomatic obese women. Rev Assoc Med Bras. 53:344–348. 2007.(In Portuguese).
4	Dreisler E, Stampe Sorensen S, Ibsen PH and Lose G: Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20–74 years. Ultrasound Obstet Gynecol. 33:102–108. 2009.
5	Baiocchi G, Manci N, Pazzaglia M, Giannone L, Burnelli L, Giannone E, et al: Malignancy in endometrial polyps: A 12-year experience. Am J Obstet Gynecol. 201:462.e1–4. 2009.PubMed/NCBI
6	Lieng M, Istre O, Sandvik L and Qvigstad E: Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol. 16:465–471. 2009.PubMed/NCBI
7	Sant’Ana de Almeida EC, Nogueira AA, Candido dos Reis FJ, Zambelli Ramalho LN and Zucoloto S: Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas. 49:229–233. 2004.
8	Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gerhenson DM and Lu KH: Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 106:2376–2381. 2006. View Article : Google Scholar : PubMed/NCBI
9	Oguz S, Sargin A, Kelekci S, Aytan H, Tapisiz OL and Mollamahmutoglu L: The role of hormone replacement therapy in endometrial polyp formation. Maturitas. 50:231–236. 2005. View Article : Google Scholar : PubMed/NCBI
10	Onalan R, Onalan G, Tonguc E, Ozdener T, Dogan M and Mollamahmutoglu L: Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril. 91:1056–1060. 2009. View Article : Google Scholar : PubMed/NCBI
11	Belisário MS, Vassallo J, Andrade L, Alvarenga M, Pinto GA and Monteiro IM: The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index. Maturitas. 53:114–118. 2006.PubMed/NCBI
12	McGurgan P, Taylor LJ, Duffy SR and O’Donovan PJ: An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT. Maturitas. 53:454–461. 2006. View Article : Google Scholar : PubMed/NCBI
13	Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B and Karlsson MG: Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenic implications. Int J Gynecol Pathol. 21:155–160. 2002. View Article : Google Scholar : PubMed/NCBI
14	Tokyol C, Aktepe F, Dilek FH, Sahin O and Arioz DT: Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol. 28:148–156. 2009. View Article : Google Scholar : PubMed/NCBI
15	Maia H Jr, Pimentel K, Silva TM, Freitas LA, Zausner B, Athayde C, et al: Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol. 22:219–224. 2006. View Article : Google Scholar : PubMed/NCBI
16	Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H, et al: Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 100:389–395. 2009. View Article : Google Scholar : PubMed/NCBI
17	Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, Papadias K, Kondi-Pafiti A and Creatsas G: Clinical parameters linked with malignancy in endometrial polyps. Climacteric. 12:454–458. 2009. View Article : Google Scholar : PubMed/NCBI
18	Costa-Paiva L, Godoy CE Jr, Antunes A Jr, Caseiro JD, Arthuso M and Pinto-Neto AM: Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause. 18:1278–1282. 2011. View Article : Google Scholar : PubMed/NCBI
19	Harvey JM, Clark GM, Osborne CK and Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474–1481. 1999.PubMed/NCBI
20	Stuart-Harris R, Caldas C, Pinder SE and Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast. 17:323–334. 2008. View Article : Google Scholar : PubMed/NCBI
21	Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, et al: Assessment of Ki67 in breast cancer: recommendation from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 103:1656–1664. 2011. View Article : Google Scholar : PubMed/NCBI
22	Lopes RG, Baracat EC, de Albuquerque Neto LC, Ramos JF, Yatabe S, Depesr DB, et al: Analysis of estrogen- and progesterone-receptor expression in endometrial polyps. J Minim Invasive Gynecol. 14:300–303. 2007. View Article : Google Scholar : PubMed/NCBI
23	Gul A, Ugur M, Iskender C, Zulfikaroglu E and Ozaksit G: Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters. Arch Gynecol Obstet. 281:479–483. 2010. View Article : Google Scholar : PubMed/NCBI
24	Villavicencio A, Aguilar G, Argüello G, Dünner C, Gabler F, Soto E, et al: The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria. Gynecol Oncol. 117:96–102. 2010. View Article : Google Scholar : PubMed/NCBI
25	Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, et al: Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest. 61:24–28. 2006. View Article : Google Scholar : PubMed/NCBI
26	McGurgan P, Taylor LJ, Duffy SR and O’Donovan PJ: Are endometrial polyps from pre-menopausal women similar to postmenopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women. Maturitas. 54:277–284. 2006. View Article : Google Scholar : PubMed/NCBI
27	Taylor LJ, Jackson TL, Reid JG and Duffy SR: The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG. 110:794–798. 2003. View Article : Google Scholar : PubMed/NCBI
28	Amalinei C, Cianga C, Balan R, Cianga P, et al: Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. Ann Anat. 193:43–55. 2011. View Article : Google Scholar
29	Erdemoglu E, Güney M, Karahan N and Mungan T: Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas. 59:268–274. 2008. View Article : Google Scholar : PubMed/NCBI
30	Nishimura S, Manabe I and Nagai R: Adipose tissue in obesity and metabolic syndrome. Discov Med. 8:55–60. 2009.
31	Byers T and Sedjo RL: Does intentional weight loss reduce cancer risk? Diabetes Obes Metab. 13:1063–1072. 2011. View Article : Google Scholar : PubMed/NCBI